Germ cell lineage differentiation in non-seminomatous germ cell tumours

被引:62
|
作者
Honecker, F
Stoop, H
Mayer, F
Bokemeyer, C
Castrillon, DH
Lau, YFC
Looijenga, LHJ
Oosterhuis, JW
机构
[1] Erasmus MC Univ, Dept Pathol, Med Ctr Rotterdam, Josephine Nefkens Inst,Daniel Den Hoed Canc Ctr, NL-3000 DR Rotterdam, Netherlands
[2] Univ Hamburg, Dept Hematol Oncol, Hamburg, Germany
[3] Univ Tubingen, Dept Hematol Oncol, Tubingen, Germany
[4] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75230 USA
[5] Univ Calif San Francisco, Div Cell & Dev Genet, Dept Med, VA Med Ctr, San Francisco, CA 94143 USA
来源
JOURNAL OF PATHOLOGY | 2006年 / 208卷 / 03期
关键词
germ cell tumours; germ cell lineage; differentiation; totipotency; primordial germ cells;
D O I
10.1002/path.1872
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human germ cell tumours (GCTs) have long fascinated investigators for a number of reasons. Being pluripotential tumours, they can differentiate into both extra-embryonic and embryonic (somatic) tissues. However, it has never been shown convincingly that, in humans, these tumours are truly totipotent and can also give rise to the germ lineage, the third major differentiation lineage occurring early during embryonic life. Using a number of newly available, distinct, immunohistochemical markers, such as OCT3/4, VASA and TSPY, the occurrence of germ cells was investigated in a number of germ cell tumours. Development of germ cells was identified in three independent non-seminomas, including two pure yolk sac tumours and one mixed tumour composed of yolk sac tumour and immature teratoma. Our finding indicates a previously unknown totipotent potential of human GCTs and raises the question of whether, under certain culture conditions, primordial germ cells could be derived from human GCT cell lines. Copyright (c) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:395 / 400
页数:6
相关论文
共 50 条
  • [21] TREATMENT OF NON-SEMINOMATOUS GERM-CELL TUMORS OF TESTIS
    BRINKLEY, D
    PRYOR, JP
    LANCET, 1983, 1 (8319): : 298 - 298
  • [22] METASTATIC NON-SEMINOMATOUS GERM-CELL TUMOR AND DERMATOMYOSITIS
    BARKER, RA
    CURRIE, DC
    HORWICH, A
    SPIRO, SG
    POSTGRADUATE MEDICAL JOURNAL, 1990, 66 (771) : 59 - 60
  • [23] SEOM guidelines: non-seminomatous germ cell cancer (NSGCC)
    Pablo Maroto
    Xavier García del Muro
    Javier Sastre
    Dolores Isla
    Clinical and Translational Oncology, 2011, 13 : 565 - 568
  • [24] Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours
    Maroto, P
    del Muro, XG
    Aparicio, J
    Paz-Ares, L
    Arranz, JA
    Guma, J
    Terrassa, J
    Barnadas, J
    Dorta, J
    Germà-Lluch, JR
    ANNALS OF ONCOLOGY, 2005, 16 (12) : 1915 - 1920
  • [25] Complications of venous access port (VAP) in patients with non-seminomatous testicular germ cell tumours
    Hoekstra, H
    Lemmers, N
    Gels, M
    Droste, J
    deLangen, Z
    Plukker, J
    Sleijfer, D
    Koops, HS
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1210 - 1210
  • [26] Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy
    Bower, M
    Newlands, ES
    Holden, L
    Rustin, GJS
    Begent, RHJ
    ANNALS OF ONCOLOGY, 1997, 8 (05) : 477 - 483
  • [27] Predictive factors for residual teratoma after chemotherapy for non-seminomatous germ cell tumours (NSGCT)
    Larsen, LH
    von der Maase, H
    GERM CELL TUMOURS V, 2002, : 157 - 158
  • [28] The management of non-seminomatous germ-cell tumours patients with viable malignancy at the time of RPLND
    Huddart, R. A.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 203 - 204
  • [29] Postorchiectomy markers elevation only in non-seminomatous germ-cell tumours (NSGCT) of the testis
    Pizzocaro, G
    Nicolai, N
    Piva, L
    Salvioni, R
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 918 - 918
  • [30] Adjuvant chemotherapy in high-risk stage I non-seminomatous germ cell tumours:: the Spanish germ cell cancer group experience
    Maroto, P
    del Muro, XG
    Lomas, M
    Almenar, D
    Aparicio, J
    Bastús, R
    López-Brea, M
    de la Vega, RL
    Lizón, J
    Terrasa, J
    Pérez, R
    Tejedor, M
    Arranz, JA
    Alba, E
    Diz, P
    Paz-Ares, L
    Sancho, JF
    Germa-Lluch, FR
    GERM CELL TUMOURS V, 2002, : 242 - 242